UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000011440
Receipt No. R000013393
Scientific Title Phase II study of panitumumab rechallenge in the third-line therapy in patients with KRAS wild-type metastatic colorectal cancer
Date of disclosure of the study information 2013/08/12
Last modified on 2019/03/08 10:10:05

No. Disposal Last modified on Item of update
1 Insert 2013/08/10 09:49:30
2 Update 2013/11/20 11:28:27 TEL
Email
Last name of contact person
Last name of contact person
Email
Institutions
3 Update 2013/11/20 12:56:57 Last name of contact person
Last name of contact person
4 Update 2016/11/15 13:32:19 Key inclusion criteria
5 Update 2016/11/15 13:32:58 Name of primary sponsor
Organization
Organization
6 Update 2016/11/15 13:34:02 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
7 Update 2018/01/17 12:03:13 Recruitment status
8 Update 2019/03/08 10:10:05 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results


Contact us.